Acid Maltase Deficiency (AMD)

Acid maltase deficiency is also called Pompe disease, glycogenosis type 2, acid-alpha glucosidase deficiency, and lysosomal storage disease. It is a metabolic muscle disorder that interferes with how the body processes food to produce energy.

Illustration of DNA
Blog Post

Simply Stated: What Is Neuromuscular Disease?

By Amy Bernstein | June 8, 2022
Blog Post

MDA Partners on Pilot Program in North Carolina to Screen Babies for DMD

By Brittany Hernandez | September 7, 2020
Featured Article

MDA’s 2020 Advocacy Agenda Update

By Mark Fisher | August 14, 2020
Blog Post

Hacking COVID: MDA Staff Edition

By MDA Staff | June 18, 2020
Featured Article

Pompe Disease Treatment Is Moving Forward

By MDA Staff | May 15, 2020
Blog Post

MDA’s 2020 Advocacy Plan

By Mark Fisher | January 27, 2020
Featured Article

A Good Beginning: Newborn Screening

By Donna Albrecht | January 17, 2020
Blog Post

New MDA Educational Programs for Clinicians Offer a Detailed View on Selected Topics in Neuromuscular Disease

By MDA Staff | December 13, 2019
Blog Post

World Muscle Society Roundup: Clinical Trial Results of Treatments in Development for DMD, XLMTM, SMA, and Pompe Disease

By Jeanene Swanson | October 31, 2019
Blog Post

Clinical Trial Alert: Amicus Therapeutics Seeks Participants for a Phase 3 Late-Onset Pompe Disease Study

By MDA Staff | October 16, 2019